PTC THERAPEUTICS, INC. — Director's Dealing 2015

Jun 11, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2015-06-10

Reporting Person: STEELE GLENN JR MD PHD (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-10	Stock Option (Right to Buy)	$53.90	A	20000	Acquired	2025-06-09	Common Stock (20000)	Direct

Footnotes

F1: This option award vests over three years in equal increments upon each anniversary of the date of grant. Granted upon the election of the Reporting Person as non-employee director of the Issuer.